AZMATICS: AZithroMycin/Asthma Trial In Community Settings

PHASE3CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Asthma
Interventions
DRUG

Azithromycin

600 mg x 3 days, then 600 mg weekly x 11 weeks

DRUG

Placebo

Matching placebo

Trial Locations (5)

44130

RAP - Cleveland Clinic, Cleveland

53713

Wisconsin Research and Education Network (WREN), Madison

61602

ANSR, Peoria

66211

AAFP National Research Network, Kansas City

73104

University of Oklahoma Health Sciences Center (OUHSC) and Oklahoma Physicians Resource/Research Network (OKPRN), Oklahoma City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

American Academy of Family Physicians

OTHER

collaborator

Dean Foundation

OTHER

collaborator

Pfizer

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT00266851 - AZMATICS: AZithroMycin/Asthma Trial In Community Settings | Biotech Hunter | Biotech Hunter